Articles tagged with “overall-survival”

ASCO 2026: Ivonescimab HARMONi-6 Trial Results for NSCLC

Examine ASCO 2026 HARMONi-6 trial data for ivonescimab in 1L squamous NSCLC. Understand OS outcomes, PD-1xVEGF efficacy, and Summit Therapeutics US strategy.

45 min read

5/15/2026

ivonescimab harmoni-6 trial asco 2026 squamous nsclc pd-1xvegf bispecific summit therapeutics oncology clinical trials lung cancer therapy akeso biopharma overall survival